The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID

Sara L. Pucci, Allison Veide, Haley Pierce, Dana Kaminski

Open source

DOI: 10.9740/mhc.2026.06.125
Published: 2026-06
Container: Mental Health Clinician
Publisher: American Association of Psychiatric Pharmacists (AAPP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.9740/mhc.2026.06.125,
  title = {The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID},
  author = {Sara L. Pucci and Allison Veide and Haley Pierce and Dana Kaminski},
  year = {2026},
  journal = {Mental Health Clinician},
  doi = {10.9740/mhc.2026.06.125},
  url = {https://doi.org/10.9740/mhc.2026.06.125}
}

RIS

TY  - JOUR
TI  - The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID
AU  - Sara L. Pucci
AU  - Allison Veide
AU  - Haley Pierce
AU  - Dana Kaminski
PY  - 2026
JO  - Mental Health Clinician
DO  - 10.9740/mhc.2026.06.125
UR  - https://doi.org/10.9740/mhc.2026.06.125
ER  -

APA

Pucci, S. L., Veide, A., Pierce, H., & Kaminski, D. (2026). The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID. Mental Health Clinician. https://doi.org/10.9740/mhc.2026.06.125

Source records

crossref · retrieved 2026-09-26T17:05:31.183Z